Gufic Biosciences Limited has informed the Exchange regarding Change in Auditors of the company.
GUFICBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gufic Biosciences has informed the stock exchanges that its Board of Directors approved the re-appointment of M/s. Mittal Agarwal & Co., Chartered Accountants (FRN: 131025W) as the company's Statutory Auditors on August 13, 2025. This is the firm's second term, covering 5 consecutive years from the upcoming 41st Annual General Meeting (AGM) until the conclusion of the 46th AGM in 2030. The re-appointment is subject to shareholder approval at the ensuing AGM. Mittal Agarwal & Co., established in 2010, is a Mumbai-based firm with over 40 professionals and 8 qualified Chartered Accountants, holding ICAI peer-review certification. The firm will continue to provide audit, taxation, and advisory services to the company.
This is a routine, positive governance action — continuity of the existing auditor for another 5-year term suggests no audit concerns or governance disruptions. Shareholders will vote to ratify this at the upcoming AGM, but no immediate impact on stock price is expected.